Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of surovatamig (AZD0486) monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior lines of therapies. The study has 2 Modules: Module 1 for FL and Module 2 for LBCL.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat i więcej
- •Potwierdzona histologicznie nawrotowa lub oporna na leczenie choroba (po co najmniej 2 poprzednich leczeniach)
- •Dobry stan ogólny (ECOG 0-2)
- •Wykrycie białka CD-19 na komórkach chłoniaka
- •Widoczna choroba w badaniach obrazowych (guzy węzłów lub innych narządów o określonych rozmiarach)
- •Prawidłowa liczba krwinek białych, płytek krwi i hemoglobiny
- •Prawidłowa funkcja wątroby i nerek
- •Prawidłowa funkcja serca (wyfrancja lewej komory ≥45%)
✗ Disqualifies
- •Rozpoznanie białaczki limfocytowej, chłoniaka Burkitta lub transformacji Richtera
- •Zaangażowanie ośrodkowego układu nerwowego (mózgu lub rdzenia kręgowego)
- •Chłoniak w postaci białaczki (komórki w krwi obwodowej)
- •Historia problemów neurologicznych wymagających leczenia w ostatnim roku (epilepsja, udar, demencja, poważne zaburzenia psychiczne)
- •Leczenie innymi terapiami celowanymi w ciągu 6-12 tygodni przed badaniem (terapie CAR-T, przeszczep szpiku)
- •Aktywna infekcja lub inne poważne schorzenia utrudniające udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (94)
Research Site
Phoenix, United States
Research Site
Duarte, United States
Research Site
Jacksonville, United States
Research Site
Tampa, United States
Research Site
Chicago, United States
Research Site
Iowa City, United States
Research Site
Waukee, United States
Research Site
Overland Park, United States
Research Site
Rochester, United States
Research Site
St Louis, United States
Research Site
New Brunswick, United States
Research Site
New York, United States
Research Site
Charlotte, United States
Research Site
Columbus, United States
Research Site
Portland, United States
Research Site
Philadelphia, United States
Research Site
Pittsburgh, United States
Research Site
Pittsburgh, United States
Research Site
Nashville, United States
Research Site
Austin, United States
Research Site
Houston, United States
Research Site
San Antonio, United States
Research Site
Milwaukee, United States
Research Site
Heidelberg, Australia
Research Site
Kogarah, Australia
Research Site
Macquarie University, Australia
Research Site
Nedlands, Australia
Research Site
Porto Alegre, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
Barrie, Canada
Research Site
Brampton, Canada
Research Site
Ottawa, Canada
Research Site
Toronto, Canada
Research Site
Chengdu, China
Research Site
Chengdu, China
Research Site
Guangzhou, China
Research Site
Nanchang, China
Research Site
Nanjing, China
Research Site
Nantong, China
Research Site
Shandong, China
Research Site
Shanghai, China
Research Site
Shanghai, China
Research Site
Tianjin, China
Research Site
Zhengzhou, China
Research Site
Aalborg, Denmark
Research Site
Copenhagen, Denmark
Research Site
Vejle, Denmark
Research Site
Montpellier, France
Research Site
Paris, France
Research Site
Pierre-Bénite, France
Research Site
Rouen, France
Research Site
Berlin, Germany
Research Site
Chemnitz, Germany
Research Site
Essen, Germany
Research Site
Jena, Germany
Research Site
Würzburg, Germany
Research Site
Hong Kong, Hong Kong
Research Site
Shatin, Hong Kong
Research Site
Alessandria, Italy
Research Site
Bologna, Italy
Research Site
Busto Arsizio, Italy
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Roma, Italy
Research Site
Chiba, Japan
Research Site
Kashiwa, Japan
Research Site
Kōtoku, Japan
Research Site
Kumamoto, Japan
Research Site
Niigata, Japan
Research Site
Okayama, Japan
Research Site
Osaka, Japan
Research Site
Yokohama, Japan
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Madrid, Spain
Research Site
Pozuelo de Alarcón, Spain
Research Site
Gothenburg, Sweden
Research Site
Stockholm, Sweden
Research Site
Kaohsiung City, Taiwan
Research Site
Kaohsiung City, Taiwan
Research Site
Taichung, Taiwan
Research Site
Taichung, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan
Research Site
London, United Kingdom
Research Site
Manchester, United Kingdom
Research Site
Norwich, United Kingdom
Research Site
Nottingham, United Kingdom
Research Site
Plymouth, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.